Skip to main content
Signal8
Hambleton Julie profile photo

Julie Hambleton

CIK: 0001578771

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Erasca, Inc. logo
ERAS

Erasca, Inc.

Director
IGM Biosciences, Inc. logo
IGMS

IGM Biosciences, Inc.

Director
SpringWorks Therapeutics, Inc. logo
SWTX

SpringWorks Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Erasca, Inc. logo
    ERAS

    Erasca, Inc.

    Jun 26, 2026
    Award(A)

    Stock option (right to buy)

    Direct
    29.9K shares-
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Aug 14, 2025
    Disposition(D)
    Direct
    2K shares-
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    Jul 1, 2025
    Disposition(D)
    Direct
    14.2K shares-
  • Erasca, Inc. logo
    ERAS

    Erasca, Inc.

    Jun 24, 2025
    Award(A)

    Stock option (right to buy)

    Direct
    120K shares-
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    May 14, 2025
    Award(A)
    Direct
    10.1K shares-
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    Feb 10, 2025
    Sale(S)
    Direct
    13.8K shares at avg. $53.01$730K
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    Feb 10, 2025
    Exercise(M)
    Direct
    13.8K shares at avg. $32.27$444K

1-7 of 7

About Hambleton Julie

Hambleton Julie (SEC CIK 0001578771) files insider reports with the SEC as Director of Erasca, Inc. (ERAS), Director of IGM Biosciences, Inc. (IGMS) and Director of SpringWorks Therapeutics, Inc. (SWTX).

Signal8 holds 6 ownership filings by Hambleton Julie, all Form 4s, filed between Feb 12, 2025 and Jun 29, 2026. Those filings report 7 transactions, from Feb 10, 2025 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hambleton Julie's filings is in SAN DIEGO, CA.

Recent filings by Hambleton Julie

  • Jun 26, 2026: Grant or award of ERAS derivative securities (Form 4, code A).
  • Aug 14, 2025: Disposition to issuer transaction of IGMS shares (Form 4, code D).
  • Jul 1, 2025: Disposition to issuer transaction of SWTX shares (Form 4, code D).
  • Jun 24, 2025: Grant or award of ERAS derivative securities (Form 4, code A).
  • May 14, 2025: Grant or award of SWTX shares (Form 4, code A).

Other insiders filing for Erasca, Inc. (ERAS)

How to read Form 4 transaction codes